Abbott's Xience Prime & Xience V drug eluting stents gets CE Mark in Europe ... pharmabiz.com Abbott's Xience Prime and Xience V Everolimus eluting coronary stent systems have received CE Mark in Europe for the use of dual anti-platelet therapy (DAPT) for at least three months after stent implantation in patients with coronary artery disease. CIBELES: Xience Stands Up to Cypher for CTO PCI |
